Clinical Trial Update: Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial [Phase 3]

View source ↗

Summary

A phase 3 randomized trial comparing the Gastric Modulator TANTALUS System to insulin in obese patients with type 2 diabetes is described; the current status of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tantalus System

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN